Smoke Stopper: Niantic Chemist Is Behind Latest Antismoking Drug

Summary

---

The vast majority of research scientists labor in obscurity, contributing important insights but never seeing their name attached to a commercial drug. Jotham W. Coe, a research fellow in the neuroscience department of Pfizer Global Research and Development, has beaten those odds. He has been traveling around the country giving presentations on how he discovered the science behind Chantix, Pfizer's new antismoking pill.

Chantix, or varenicline tartrate, went on the market earlier this month. Smokers take the drug in pill form for 12 weeks while following a support program designed to help them make behavioral changes.

See the full content of this document

Extract

---

Smoke Stopper: Niantic Chemist Is Behind Latest Antismoking Drug

Unlike nicotine patches and gum, which replace nicotine in the body, Chantix works by stimulating the production of dopamine, as nicotine does, but at a more stable level and...

See the full content of this document

---